Mumbai, Sept. 7 -- MedTherapy Biotechnology Inc., a corporation incorporated under the laws of the State of Delaware, USA. MedTherapy Biotech is Boston based global cancer cell & gene therapy company founded in 2018 by experts from Harvard and former Novartis executives as an end-to-end, integrated CAR-T Cell CDMO, with commercial scale GMP manufacturing facility in New Delhi, India and technology development site at Boston, USA.

Sudarshan Pharma stated that this acquisition would help the company enter the U.S. market and establish a presence there. It would also receive access the customer base, contracts, distribution network, eventually helping the company to expand into new products and services.

The consideration, which would be p...